Provided by Tiger Trade Technology Pte. Ltd.

Repare Therapeutics Inc.

2.15
-0.0650-2.93%
Volume:455.45K
Turnover:991.84K
Market Cap:92.42M
PE:-1.27
High:2.22
Open:2.22
Low:2.15
Close:2.22
52wk High:4.07
52wk Low:0.8900
Shares:42.99M
Float Shares:22.72M
Volume Ratio:1.65
T/O Rate:2.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6944
EPS(LYR):-1.9969
ROE:-49.78%
ROA:-29.72%
PB:0.80
PE(LYR):-1.08

Loading ...

Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 28, 2024

Major Issues Report

Form 8-K - Current report
Aug 16, 2024

Correspondence

Form CORRESP - Correspondence
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
May 24, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Major Issues Report

Form 8-K - Current report
Apr 26, 2024

Major Issues Report

Form 8-K - Current report
Mar 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities